Tony Huge

Ivermectin for Toxoplasma Brain Cysts? What the Research Shows: Tony Huge’s Video Guide

Table of Contents

One in three people carries Toxoplasma gondii, the parasite that makes rodents walk toward cats and keeps turning up in studies on risk-taking and schizophrenia. Almost nobody is tested for it, and every approved drug targets the fast-moving stage while leaving the walled brain cysts alone. Tony Huge has taken ivermectin prophylactically for years after a life spent around cats. In this video he lays out the parasite’s biology, the testing that actually dates an infection, and a 2023 mouse study where a single dose of ivermectin cut brain cysts by 68.85%.

Video: Ivermectin for Toxoplasma Brain Cysts? What the Research Actually Shows. Published August 23, 2026. Watch on YouTube.

What the video covers

Why the cyst is the whole problem

Tony’s mechanism explanation is what makes the rest of the video land. Toxoplasma runs in two stages. The tachyzoite divides fast, spreads, and causes the first illness, which may feel like a mild flu or nothing at all. The immune system fights it and usually wins. Then the parasite converts into the bradyzoite, slows almost to a stop, and wraps itself in a wall built from your own tissue, preferring brain and muscle. A cyst like that is metabolically quiet, and almost every drug we have works by interrupting a process. An antibiotic on a bacterium that is not reproducing does nothing; a drug aimed at a parasite that has stopped moving has nothing to interfere with.

That is why the standard treatments, pyrimethamine with sulfadiazine, trimethoprim-sulfamethoxazole, clindamycin, spiramycin, atovaquone combinations, are aimed at the fast stage. A person gets diagnosed, gets treated, gets told they are cured, and walks out still carrying reservoir pockets in the brain. Tony says that is the lesson to take everywhere: ask what a drug is aimed at, not what it was approved for.

On testing, he is specific. The standard test is Toxoplasma IgG, cheap and available, and it tells you whether you have ever been exposed. The better version is IgG with reflex avidity, where a positive IgG automatically triggers an avidity assay on the same sample. High avidity means the infection is at least three to four months old, and Tony cites a head-to-head comparison of four commercial avidity tests where a high result confirmed a latent infection every time in all four. IgM is the test people assume dates an infection, and it does not, because residual IgM can persist for years.

The cyst count study

Tony cites the study as Journal of Parasitic Diseases, 2023, open access. Fifty-eight female Swiss mice were each given 100 cysts of the ME49 strain, the cyst-forming strain used for chronic infection, and run on dexamethasone to suppress the immune system, making it a reactivation model. The researchers then waited 45 days before treating anything, so the cysts had already built and walled off. At day 55 they blended half of each brain in one milliliter of fluid and counted cysts under a microscope.

Untreated mice averaged 700.8 cysts in that sample, a sevenfold multiplication from the 100 they swallowed. Spiramycin brought that to 310, a 55.76% reduction. Ivermectin brought it to 218.3, a 68.85% reduction. Then the dosing comparison: the spiramycin mice got 200 mg/kg per day by tube for ten days straight. The ivermectin mice got 2 mg/kg once, and nothing after. Tony’s summary is that spiramycin delivered roughly a thousand times more drug for a smaller result.

“The drug cleared an infection in the brain and then the body did the rest.”

Tony Huge, 09:15

The second half of the study is the part he cares about more, because a cyst count is a number and this is a function. The researchers stained brain slices for GABA, the main inhibitory neurotransmitter, the brakes on the nervous system. Healthy mice sit at 100%. Infected, untreated mice were at 18%. Spiramycin brought them to 52%. Ivermectin brought them to 92%. And ivermectin given to uninfected mice produced 104% against 103% for uninfected mice with no drug, meaning in a healthy brain it did nothing to GABA at all. The parasite was crushing GABA, and removing the parasite let it come back.

The door the parasite opens

Here is the mechanism Tony finds most interesting, and it cuts both ways. Ivermectin crosses a healthy blood-brain barrier poorly, and so does spiramycin, so neither should have worked this well in the brain. The authors’ explanation is that Toxoplasma damages the lining of the brain’s blood vessels. The barrier gets leaky, and the infection itself lets the drug in. The parasite opened a door the drug could not open on its own.

The same leak is the risk. In worms, ivermectin jams a chloride channel mammals do not have. But the mammalian brain has close relatives of that channel on the GABA system, and once the barrier is leaky, ivermectin can reach them. The documented consequence in animals is seizures, circling, and loss of the ability to walk. Tony tells the story of a small dog that ate an entire package of his ivermectin, an estimated 200 to 300 times its body-weight dose, had seizures, was declared likely blind and unable to walk again, and recovered after he rehabilitated it with other supplements. He takes responsibility for the storage, and uses it as a demonstration of how dangerous a high dose is once it reaches the brain.

Why ivermectin, and what else exists

Tony pre-empts the horse dewormer line. Ivermectin was FDA approved for humans in 1987, sits on the WHO list of essential medicines, has had more than five billion doses donated against river blindness, and earned its discoverers a Nobel Prize in 2015. It has a veterinary formulation the way penicillin does. It is his go-to for anything parasitic because it is so well studied and so widely available, and he says he has a place in his heart for it.

He is fair to the alternatives. Atovaquone with proguanil was tested in chronic mouse infection with a widely repeated 85% cyst reduction. Black seed oil, curcumin, artemisinin and wormwood, berberine, oregano oil, garlic, and clove have some published anti-Toxoplasma activity. But the popular parasite cleanses built on fenbendazole, mebendazole, albendazole, black walnut, and wormwood are worm drugs aimed at structures that exist inside worms. Toxoplasma is a single-celled protozoan with different machinery.

He also presents the disagreement in the literature. The popular story is that cysts rewire a rodent’s fear circuitry. A 2021 Trends in Parasitology paper argues cyst location is neither necessary nor sufficient, and that the real driver is a hormonal route through gonadal steroids. If that paper is right, clearing 68.85% of cysts does not automatically restore behavior. Both are peer reviewed, and they disagree.

Cheat Sheet Pivot

What Tony reported doing and what the cited study used, not a protocol.

  • Tony has taken ivermectin prophylactically and as a periodic detox, never having been tested for Toxoplasma himself, on the reasoning that a life around cats makes him a likely carrier.
  • The mouse study used a single oral 2 mg/kg dose in immunosuppressed mice with established cysts; the comparator was 200 mg/kg/day of spiramycin for ten days.
  • His view of frequency: a parasite cleanse is something to do once in a while, not weekly or monthly, which he considers part of why the benefit outweighs the risk for him.
  • The risk he watches is neurological, driven by the fact that an infected brain lets more drug through, and he explicitly wants a study on minimum effective dose for this application.
  • His action item for viewers is testing: ask whether Toxoplasma IgG with reflex avidity is available at the next blood draw.

Ivermectin and the other antiparasitics Tony has covered are in the Miracle Molecules Cheat Sheet. For the history and politics behind the horse dewormer framing, read A Nobel Prize-Winning Drug Used 4 Billion Times in Humans. For another antiparasitic with a longevity angle, see Niclosamide: The Antiparasitic Longevity Compound Guide.

Where the evidence stops

Tony says it plainly: this is a mouse result, a strong model that has not been run in people, and he could not find a study on ivermectin and latent toxoplasmosis anywhere. He is operating on mechanism and biological logic, the similarity of the mouse blood-brain barrier to the human one, because the human research does not exist. His explanation is the patent one: ivermectin costs about as much as vitamin C, nobody profits from proving it works, and there is political bias against it besides.

Ivermectin is an approved antiparasitic in most Western countries and is not approved anywhere for latent toxoplasmosis. Tony’s own forecast is a cyst-active agent reaching approval around 2032. The video documents a hypothesis he is testing on himself, and he frames it as exactly that.

Keep going

For Tony’s take on parasite panic more generally, read Viral Sushi Parasites: Tony Huge’s Take on Biohacking Claims. Companion articles for new videos arrive through the tonyhuge.is email list, and the rest of the archive is at tonyhuge.is.

Popular Category